The evidence review for this chapter included an update of a previous Cochrane review296 in addition to a new search of the Cochrane Kidney and Transplant Registry for all RCTs. The term high BP is used throughout the document for BP above the target. For kidney transplant recipients, the target is SBP <130 mm Hg/DBP <80 mm Hg. Practice Point 4.1: Treat adult kidney transplant recipients with high BP to a target BP of <130 mm Hg systolic and <80 mm Hg diastolic using standardized of ce BP measurement (see Recommendation 1.1). This practice point is identical to the original recom- mendation put forward in the KDIGO 2012 Clinical Practice Guideline for the Management of Blood Pressure in Chronic The target is also consistent with the rec- ommended target of <130/80 mm Hg as de ned in the KDIGO Clinical Practice Guideline for the Care of Kidney There are no completed RCTs in kidney transplant re- cipients that have tested different BP targets on clinically important outcomes such as graft survival, CV events, or mortality. There is only 1 RCT on intensi ed BP control in kidney transplant recipients that compared to standard blood pressure (MAP between 50th and 99th percentiles) versus intensi ed BP control (MAP <50th percentile), and it did not report on any clinical outcomes.298 The Work Group judged that a target of <130 mm Hg systolic, using standardized of ce measurement, remained a reasonable goal for kidney transplant recipients. 